Posted by Michael Wonder on 24 Jan 2021
Canada’s drug makers rattle their sabers over a government plan to control medicine spending
21 January 2021 - A majority of pharmaceutical executives in Canada say new regulations designed to cut prescription drug spending by the Canadian government are delaying product launches and R&D investment and will subsequently hurt employment, according to a new survey sponsored by an industry trade group.
Specifically, 94% of 43 executives queried project product launches will be delayed by a year or more, and 35% indicated delays already occurred.
